Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1)Planning ...

Poor saliva control (sialorrhoea) represents a considerable burden to paediatric patients with neurodevelopmental ...

In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with preservation of lean mass, outperforming the group given ...

BACKGROUND: Previous studies have shown that preloading an antagonist muscle may increase the acute agonist neuromuscular performance. In addition, studies have suggested that very short-term ...

Discover how sansho, Japan’s tingling spice, bridges tradition and science with proven roles in gut balance, pain relief, and metabolic wellness.

Intercept Pharmaceuticals withdraws Ocaliva from the U.S. market following FDA concerns over safety and effectiveness for ...

Read the latest analysis on ImmunityBio stock: strong Anktiva NMIBC data but slow sales and valuation concerns.

UCB Canada Inc. is proud to announce that the pan-Canadian Pharmaceutical Alliance (pCPA) has successfully concluded negotiations for PrZILBRYSQ® ...

HBC has today released a whitepaper demonstrating how its bioactive peptide ingredient ProGo® uniquely provides complete GLP-1 support. To maximize the effect of GLP-1 therapy, lean muscle mass needs ...

Get insights from Denali Therapeutics’ CEO on blood-brain barrier therapies, regulatory milestones, and biotech innovation.

The legal claims against Novo Nordisk are not about banning the drug. They are about accountability and informed consent. The core ...